TY - JOUR
T1 - Colorectal cancer in 2014
T2 - Progress in defining first-line and maintenance therapies
AU - Hubbard, Joleen M.
AU - Grothey, Axel
PY - 2015/1/1
Y1 - 2015/1/1
N2 - The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.
AB - The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.
UR - http://www.scopus.com/inward/record.url?scp=84923202077&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84923202077&partnerID=8YFLogxK
U2 - 10.1038/nrclinonc.2014.233
DO - 10.1038/nrclinonc.2014.233
M3 - Review article
C2 - 25560533
AN - SCOPUS:84923202077
VL - 12
SP - 19
EP - 20
JO - Nature Reviews Gastroenterology and Hepatology
JF - Nature Reviews Gastroenterology and Hepatology
SN - 1759-5045
IS - 1
ER -